BIOMARKER:

NRG1 mutation

Entrez ID:

Related biomarkers:

‹

›

NRG1 mutation NRG1 mutation	Squamous Cell Carcinoma of Head and Neck SCCHN	NRG1 mutation NRG1 mutation	Squamous Cell Carcinoma of Head and Neck SCCHN	cetuximab + ISU104 Sensitive: C3 – Early Trials	cetuximab + ISU104 Sensitive: C3 – Early Trials
NRG1 mutation NRG1 mutation	Pancreatic Cancer Pancreatic Cancer	NRG1 mutation NRG1 mutation	Pancreatic Cancer Pancreatic Cancer	afatinib + pertuzumab Sensitive: C3 – Early Trials	afatinib + pertuzumab Sensitive: C3 – Early Trials
NRG1 mutation NRG1 mutation	Pancreatic Cancer Pancreatic Cancer	NRG1 mutation NRG1 mutation	Pancreatic Cancer Pancreatic Cancer	erlotinib + pertuzumab Sensitive: C3 – Early Trials	erlotinib + pertuzumab Sensitive: C3 – Early Trials